The Irish Times

Bausch & Lomb expands Waterford contact lens plant

Production lines for new lenses will create 100 jobs over the next four years

Tue Nov 13 2018 - 13:01

Perrigo sells Tysabri rights to Royalty Pharma in €2.7bn deal

Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013

Tue Feb 28 2017 - 16:00

Perrigo makes board changes under pressure from activist investor

Dublin-based drugmaker was urged last year to explore a sale of its prescription business

Tue Feb 07 2017 - 15:19

Valeant is selling assets to help pay down long-term debt

Announcement by Canadian pharmaceutical company drives its shares up by 13%

Tue Aug 09 2016 - 19:10

Failed Perrigo suitor Mylan sees revenues rise on generic drugs

Dutch-domiciled US group says it is still fully committed to planned $7.2bn takeover of Sweden’s Meda

Tue May 03 2016 - 12:53

Cantillon: Valeant swipes Papa from Perrigo

What Papa brings to the party is a depth of experience from over 30 years in the business

Tue Apr 26 2016 - 01:00

Perrigo pays executives bonuses for fending off Mylan offers

Dublin-based drugmaker’s chief executive Joe Papa receives additional stock and bonus

Wed Mar 09 2016 - 09:01

Perrigo executives head for Israel in battle against Mylan

CEO Joe Papa and CFOJudy Brown hope to persuade Israeli holders of 10% of company not to accept takeover offer

Mon Oct 26 2015 - 16:05

Irish takeover panel rejects Perrigo's request over Mylan offer

Offer from Mylan remains valid and capable of acceptance by Perrigo shareholders

Tue Oct 13 2015 - 11:03

Perrigo files lawsuit against suitor Mylan

Irish pharma company claims Mylan’s $27bn offer overstates potential synergies and makes false claims

Fri Sept 18 2015 - 18:09

Mylan ready to make $33 billion hostile bid for Perrigo

Company’s shareholders vote to move forward with mega-merger of pharma groups

Fri Aug 28 2015 - 19:40

Drug firm Perrigo buys OTC portfolio of drugs from GSK

Bolt-on acqusition strengthens position in Europe amid three-way takeover battle

Tue Jun 02 2015 - 19:34

Cantillon: Perrigo at wrong end of another deal

Perrigo chief executive Joe Papa and Mylan chairman Robert Coury talking about merger for some time

Sat Apr 11 2015 - 02:22

Perrigo offloads Elan Alzheimer drug candidate

Company does deal with partner Transition Therapeutics as it separately spends $51m on over-the-counter products in Australia

Sat Mar 01 2014 - 01:00

Perrigo reports record revenues

Growth driven by strong new product sales

Sat Feb 08 2014 - 01:00

Takeover of Elan the perfect fit in Perrigo’s prescription for growth

For Perrigo chief Joe Papa, the acquisition of Ireland’s largest indigenous drug company was a ‘perfect gateway’ in its plans to expand internationally

Fri Feb 07 2014 - 01:00

Cantillon: Curtain comes down on Elan

Perrigo completes acquisition of Irish drugs firm in $8.6bn deal

Thu Dec 19 2013 - 08:39

US drugmaker Perrigo to buy Elan for $8.6 billion

Ireland’s low corporate tax rate will cut US firm’s effective tax rate to the ‘high teens’

Mon Jul 29 2013 - 08:01